Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20106 | 412 | 35.7 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2295 | 4123 | CANCER CACHEXIA//CACHEXIA//PROTEOLYSIS INDUCING FACTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DOSE BANDING | Author keyword | 4 | 75% | 1% | 3 |
2 | CHEMOTHERAPY DOSING | Author keyword | 2 | 67% | 0% | 2 |
3 | GRANULOCYTE MACROPHAGE PROGENITOR CELLS CFU GM | Author keyword | 2 | 67% | 0% | 2 |
4 | UNIT PSYCHOPHARMACOL | Address | 2 | 67% | 0% | 2 |
5 | DRUG WASTE | Author keyword | 2 | 50% | 1% | 3 |
6 | ADJUSTED BODY WEIGHT | Author keyword | 1 | 50% | 0% | 2 |
7 | ACTUAL BODY WEIGHT | Author keyword | 1 | 27% | 1% | 3 |
8 | ABSORPTION INTESTINAL | Author keyword | 1 | 50% | 0% | 1 |
9 | ANTIBIOTIC INFUSION | Author keyword | 1 | 50% | 0% | 1 |
10 | CENTRAL ELIMINATION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OVERFED RAT | 11 | 78% | 2% | 7 |
2 | INDUCED ORGAN INJURY | 8 | 70% | 2% | 7 |
3 | SIGNIFICANT WEIGHT REDUCTION | 6 | 100% | 1% | 4 |
4 | MALABSORPTION SYNDROMES | 3 | 57% | 1% | 4 |
5 | SIZE DESCRIPTOR | 3 | 57% | 1% | 4 |
6 | VORICONAZOLE SERUM CONCENTRATIONS | 2 | 67% | 0% | 2 |
7 | BILLROTH GASTRECTOMY | 1 | 100% | 0% | 2 |
8 | CAFFEINE DISPOSITION | 1 | 50% | 0% | 2 |
9 | DIGOXIN ABSORPTION | 1 | 100% | 0% | 2 |
10 | WARFARIN ABSORPTION | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Drug Disposition in Obesity: Toward Evidence-Based Dosing | 2015 | 3 | 102 | 25% |
Effect of Obesity on the Pharmacokinetics of Drugs in Humans | 2010 | 136 | 80 | 33% |
Implications of Obesity for Drug Therapy: Limitations and Challenges | 2011 | 34 | 58 | 34% |
A systematic review of drug absorption following bariatric surgery and its theoretical implications | 2010 | 49 | 27 | 48% |
Dosing chemotherapy in obese patients: Actual versus assigned body surface area (BSA) | 2009 | 31 | 46 | 52% |
Drug Dosing and Pharmacokinetics in Children With Obesity A Systematic Review | 2015 | 1 | 40 | 33% |
Dosing Considerations for Obese Patients Receiving Cancer Chemotherapeutic Agents | 2013 | 5 | 34 | 53% |
CLINICAL PHARMACOKINETICS OF DRUGS IN OBESITY - AN UPDATE | 1993 | 81 | 34 | 59% |
The challenge of obesity in paediatric leukaemia treatment: it is not just size that matters | 2015 | 1 | 27 | 26% |
Pharmacokinetic considerations in obesity | 1999 | 77 | 71 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT PSYCHOPHARMACOL | 2 | 67% | 0.5% | 2 |
2 | CLASS 3 | 1 | 50% | 0.2% | 1 |
3 | GRC 7 | 1 | 50% | 0.2% | 1 |
4 | INSERM U755 | 1 | 50% | 0.2% | 1 |
5 | KATZ GRP PHARM HLTH 2142H | 1 | 50% | 0.2% | 1 |
6 | MED ONCOL INFUS SERV | 1 | 50% | 0.2% | 1 |
7 | MOL MED HLTH BIOTECHNOL | 1 | 50% | 0.2% | 1 |
8 | PHARMACOKINET PHARMACOCHEM UNIT | 1 | 50% | 0.2% | 1 |
9 | PHARMACOL PHARMACOTHER HY | 1 | 50% | 0.2% | 1 |
10 | POST PROGRAM BIOSCI PHYSIOPATHOL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000199479 | MORPH ANAL GRP//CORE MUSCLE SIZE//INTRAMUSCULAR ADIPOSE TISSUE CONTENT |
2 | 0.0000175752 | DU BOIS AND DU BOIS//MOSTELLER FORMULA//PREDICTING EQUATION |
3 | 0.0000156968 | ARM ANTHROPOMETRY//LOW BACTERIAL DIET//NEUTROPENIC DIET |
4 | 0.0000126224 | CYP ISOZYMES//MOL RECOGNIT TECHNOL DEV IDM//CIENCIAS BASICAS FARMACEUT |
5 | 0.0000111413 | INFLAMMAT BIOL SURG SCI//ENERGY COST PER DISTANCE//IMAGING 3 DIMENSIONAL |
6 | 0.0000070597 | CLIN EXCELLENCE METAB VASC DIS//OBESITY DEGREE//POST TRANSPLANT WEIGHT GAIN |
7 | 0.0000070394 | PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM |
8 | 0.0000068313 | CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R |
9 | 0.0000066773 | UNITE MULTIDISCIPLINAIRE CHIRURG OBESITE//NUTRITIONAL DEFICIENCIES//BILIOPANCREATIC DIVERSION |
10 | 0.0000060657 | PREOXYGENATION//LUNG FUNCTIONAL RESIDUAL CAPACITY//LUNG VOLUME |